Donovan Quill, AscellaHealth’s Executive Vice President of Growth and Strategy, describes the unique challenges associated with bringing new specialty and rare disease pharmaceutical products to ...
Q3 2025 Earnings Call Transcript October 16, 2025 Snap-on Incorporated beats earnings expectations. Reported EPS is $4.71, ...